Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 4Breast 3Thoracic 2Sarcoma 2Tumor-Agnostic 1Plasma cell 1Other solid neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1

Interventions

pembrolizumab 183Cisplatin 159Radiotherapy 77Carboplatin 71Radiotherapy, Intensity-Modulated 70Cetuximab 68Magnetic Resonance Spectroscopy 65Nivolumab 64Paclitaxel 52Docetaxel 50Specimen Handling 45Radiation 34Gemcitabine 33Fluorouracil 31Surveys and Questionnaires 28Biopsy 27toripalimab 26Drug Therapy 26Platinum 25Surgical Procedures, Operative 24Standard of Care 231,2-diaminocyclohexaneplatinum II citrate 23cemiplimab 22atezolizumab 20Capecitabine 20Ipilimumab 19Chemoradiotherapy 19tislelizumab 18durvalumab 18Taxes 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Quality of Life × Head & Neck × 1 year × Clear all
NCT06633224 2025-09-16

Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT

University of California, San Francisco

Recruiting
125 enrolled
GastrointestinalHead & Neck

Gastrointestinal Neoplasms, Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡